COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:CRBD • US21871X2080

24.32 USD
+0.16 (+0.66%)
Last: Feb 10, 2026, 08:04 PM
Fundamental Rating

3

CRBD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 96 industry peers in the Financial Services industry. CRBD has a bad profitability rating. Also its financial health evaluation is rather negative. CRBD is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • CRBD had positive earnings in the past year.
  • In the past year CRBD had a positive cash flow from operations.
  • Of the past 5 years CRBD 4 years were profitable.
  • CRBD had a positive operating cash flow in 4 of the past 5 years.
CRBD Yearly Net Income VS EBIT VS OCF VS FCFCRBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

1.2 Ratios

  • With a Return On Assets value of 0.24%, CRBD is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • The Return On Equity of CRBD (7.32%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.24%
ROE 7.32%
ROIC N/A
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)N/A
ROIC(5y)N/A
CRBD Yearly ROA, ROE, ROICCRBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

  • CRBD has a Profit Margin (5.64%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of CRBD has grown nicely.
  • The Operating Margin of CRBD (12.90%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CRBD has grown nicely.
Industry RankSector Rank
OM 12.9%
PM (TTM) 5.64%
GM N/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
CRBD Yearly Profit, Operating, Gross MarginsCRBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1

2. Health

2.1 Basic Checks

  • CRBD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CRBD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CRBD Yearly Shares OutstandingCRBD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
CRBD Yearly Total Debt VS Total AssetsCRBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

  • The Debt to FCF ratio of CRBD is 6.80, which is on the high side as it means it would take CRBD, 6.80 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CRBD (6.80) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.81 indicates that CRBD is somewhat dependend on debt financing.
  • CRBD has a Debt to Equity ratio (0.81) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 6.8
Altman-Z N/A
ROIC/WACCN/A
WACC7.81%
CRBD Yearly LT Debt VS Equity VS FCFCRBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CRBD Yearly Current Assets VS Current LiabilitesCRBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

1

3. Growth

3.1 Past

  • The earnings per share for CRBD have decreased by -2.89% in the last year.
EPS 1Y (TTM)-2.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.81%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%26.42%

3.2 Future

  • CRBD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.80% yearly.
  • Based on estimates for the next years, CRBD will show a small growth in Revenue. The Revenue will grow by 5.51% on average per year.
EPS Next Y13.8%
EPS Next 2Y15.97%
EPS Next 3Y12.32%
EPS Next 5Y11.8%
Revenue Next Year8.11%
Revenue Next 2Y7.76%
Revenue Next 3Y5.76%
Revenue Next 5Y5.51%

3.3 Evolution

CRBD Yearly Revenue VS EstimatesCRBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B 25B
CRBD Yearly EPS VS EstimatesCRBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

8

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 5.17, the valuation of CRBD can be described as very cheap.
  • Based on the Price/Earnings ratio, CRBD is valued cheaper than 94.79% of the companies in the same industry.
  • CRBD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.03.
  • A Price/Forward Earnings ratio of 4.55 indicates a rather cheap valuation of CRBD.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CRBD indicates a rather cheap valuation: CRBD is cheaper than 94.79% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.97, CRBD is valued rather cheaply.
Industry RankSector Rank
PE 5.17
Fwd PE 4.55
CRBD Price Earnings VS Forward Price EarningsCRBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • CRBD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CRBD is cheaper than 72.92% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRBD indicates a rather cheap valuation: CRBD is cheaper than 82.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.82
EV/EBITDA 8.62
CRBD Per share dataCRBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • CRBD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CRBD's earnings are expected to grow with 12.32% in the coming years.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y15.97%
EPS Next 3Y12.32%

3

5. Dividend

5.1 Amount

  • CRBD has a Yearly Dividend Yield of 3.18%.
  • CRBD's Dividend Yield is a higher than the industry average which is at 2.03.
  • Compared to an average S&P500 Dividend Yield of 1.80, CRBD pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.18%

5.2 History

  • CRBD does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 52.57% of the earnings are spent on dividend by CRBD. This is a bit on the high side, but may be sustainable.
DP52.57%
EPS Next 2Y15.97%
EPS Next 3Y12.32%
CRBD Yearly Income VS Free CF VS DividendCRBD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B
CRBD Dividend Payout.CRBD Dividend Payout, showing the Payout Ratio.CRBD Dividend Payout.PayoutRetained Earnings

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64

NYSE:CRBD (2/10/2026, 8:04:00 PM)

24.32

+0.16 (+0.66%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-09
Earnings (Next)05-04
Inst Owners85.7%
Inst Owner ChangeN/A
Ins Owners0.26%
Ins Owner ChangeN/A
Market Cap12.66B
Revenue(TTM)N/A
Net Income(TTM)991.00M
Analysts78.1
Price Target29.59 (21.67%)
Short Float %0.01%
Short Ratio0.34
Dividend
Industry RankSector Rank
Dividend Yield 3.18%
Yearly Dividend0.92
Dividend Growth(5Y)N/A
DP52.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.88%
Min EPS beat(2)-13.79%
Max EPS beat(2)15.55%
EPS beat(4)2
Avg EPS beat(4)0.49%
Min EPS beat(4)-13.79%
Max EPS beat(4)15.55%
EPS beat(8)6
Avg EPS beat(8)3.22%
EPS beat(12)9
Avg EPS beat(12)5.86%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.16%
Min Revenue beat(2)-11.42%
Max Revenue beat(2)15.74%
Revenue beat(4)1
Avg Revenue beat(4)-5.62%
Min Revenue beat(4)-14.87%
Max Revenue beat(4)15.74%
Revenue beat(8)2
Avg Revenue beat(8)-14.47%
Revenue beat(12)4
Avg Revenue beat(12)-10.28%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.53%
PT rev (3m)-7.06%
EPS NQ rev (1m)-2.89%
EPS NQ rev (3m)-6.14%
EPS NY rev (1m)-1.41%
EPS NY rev (3m)-9.75%
Revenue NQ rev (1m)-0.5%
Revenue NQ rev (3m)2.81%
Revenue NY rev (1m)-0.42%
Revenue NY rev (3m)4.26%
Valuation
Industry RankSector Rank
PE 5.17
Fwd PE 4.55
P/S 0.72
P/FCF 7.82
P/OCF 7.82
P/B 0.93
P/tB 0.93
EV/EBITDA 8.62
EPS(TTM)4.7
EY19.33%
EPS(NY)5.35
Fwd EY21.99%
FCF(TTM)3.11
FCFY12.79%
OCF(TTM)3.11
OCFY12.79%
SpS33.78
BVpS26.02
TBVpS26.02
PEG (NY)0.38
PEG (5Y)N/A
Graham Number52.45
Profitability
Industry RankSector Rank
ROA 0.24%
ROE 7.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 12.9%
PM (TTM) 5.64%
GM N/A
FCFM 9.21%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.38%
ROCE(5y)1.27%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 6.8
Debt/EBITDA 4.06
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 3.58
Cash Conversion 59.72%
Profit Quality 163.37%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACC7.81%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)144.44%
Profit Quality(5y)197%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.81%
EPS Next Y13.8%
EPS Next 2Y15.97%
EPS Next 3Y12.32%
EPS Next 5Y11.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%26.42%
Revenue Next Year8.11%
Revenue Next 2Y7.76%
Revenue Next 3Y5.76%
Revenue Next 5Y5.51%
EBIT growth 1Y291.07%
EBIT growth 3Y-25.44%
EBIT growth 5Y34.3%
EBIT Next Year-5.93%
EBIT Next 3Y-0.33%
EBIT Next 5YN/A
FCF growth 1Y-47.72%
FCF growth 3Y-4.39%
FCF growth 5Y-2.53%
OCF growth 1Y-47.72%
OCF growth 3Y-4.39%
OCF growth 5Y-2.53%

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 / CRBD FAQ

Can you provide the ChartMill fundamental rating for COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64?

ChartMill assigns a fundamental rating of 3 / 10 to CRBD.


What is the valuation status of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) stock?

ChartMill assigns a valuation rating of 8 / 10 to COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD). This can be considered as Undervalued.


What is the profitability of CRBD stock?

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) has a profitability rating of 3 / 10.


What is the valuation of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 based on its PE and PB ratios?

The Price/Earnings (PE) ratio for COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) is 5.17 and the Price/Book (PB) ratio is 0.93.


What is the financial health of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) stock?

The financial health rating of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) is 1 / 10.